No Data
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of stocks for Buy conversion Market Code Stock Name Closing Price SAR Tokyo Main Board <1333> Maruha Nichiro 3163 2913 <1662> Petroleum Resources 1026893 <1721> Comsys HD 30682850 <1871> PS 14271217 <1959> Kyudenko 46804209 <2181> Persol HD 244221 <2371> Kakaku.com 24332023 <2389>
QPS Laboratory, Good Product Planning, etc. (additional) Rating
Downgrade - Bearish Code Stock Name Securities Company Previous After ---------------------------------------------------- <4676> Fuji HD Nomura "Buy" "Neutral" <6506> Yaskawa Electric Nomura "Buy" "Neutral" Target Price Change Code Stock Name Securities Company Previous After ---------------------------------------------------- <55
Rating information (Target Price change) = QPS Research, Sumitomo Chemical, ETC.
◎ Nomura Securities (3-tier: Buy > Neutral > Reduce) QPS <5595.T> -- "Buy" → "Buy", 1,361 yen → 1,628 yen. ◎ Mizuho Securities (3-tier: Buy > Hold > Underperform) Sumitomo Chemical <4005.T> -- "Buy" → "Buy", 500 yen → 450 yen. ◎ Morgan Stanley MUFG Securities (3-tier: Overweight > Equal Weight > Underweight) Japan Post Bank <7182.T> -- "Overweight" → "
Kubota, Koito Manufacturing Company ETC [List of stock materials from newspapers]
*Kubota <6326> launches 9-ton and 11-ton excavators, procured from a major Swiss company via OEM (Nikkan Kigyo, Page 3) - ○ *Mitsubishi UFJ <8306> Mitsubishi UFJ Trust Bank expands its business in Overseas and new ventures (Nikkan Kigyo, Page 4) - ○ *Yamaha Motor <7272> acquires a subsidiary for the e-kit business used in electric assist bicycles from a German company (Nikkan Kigyo, Page 8) - ○ *Koito Manufacturing <7276> restructures its subsidiary in China, establishing a two-site system for automotive lamps (Nikkan Kigyo, Page 8) - ○ *Ryobi <5851> starts Giga Casting.
Sumitomo Chemical has established a new company in Massachusetts, USA, serving as the CRO base for its CDMO business.
Sumitomo Chemical <4005.T> announced on the 1st that it has established a new company in Marlborough, Massachusetts, which will serve as a CRO base for its medical oligonucleotide CDMO business (Sumitomo Chemical Advanced Medical Solutions America LLC, SC-AMSA). The company began its contract manufacturing business for nucleic acid pharmaceuticals in 2013, and in recent years, it has been working on the mass production of long-chain nucleic acids known as gRNA, which are necessary for genome editing therapies.
Sumitomo Chemical's Strategic Move in Asian Market